Dual human epidermal growth factor receptor 2 (HER2) blockade and hormonal therapy for the treatment of primary HER2-positive breast cancer: one more step toward chemotherapy-free therapy

J Clin Oncol. 2013 May 10;31(14):1703-6. doi: 10.1200/JCO.2012.48.4998. Epub 2013 Apr 8.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Neoadjuvant Therapy / methods*
  • Neoplasm Recurrence, Local / drug therapy*
  • Receptor, ErbB-2 / analysis*

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers, Tumor
  • ERBB2 protein, human
  • Receptor, ErbB-2